N/A
ID
Bron
Verkorte titel
Aandoening
diabetes
glycemic index
glycemische index
breakfast
ontbijt
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Fasting and postprandial glucose and insulin concentrations.
Achtergrond van het onderzoek
Rationale:
Postprandial glucose excursions in diabetes mellitus are an important determinant of glycemic control. Postprandial glucose concentrations are determined by the amount and rate of carbohydrate absorption from the intestine, the prevailing insulin concentration and the potency of insulin to lower plasma glucose (insulin sensitivity). Consequently, food with lower postprandial glucose excursions (low-glycemic index food) may have a favourable effect in patients with diabetes mellitus.
Objective:
To determine the effect of breakfast replacement by a low-glycemic index (GI) liquid meal on postprandial glucose and insulin excursions, HbA1c, body weight and lipid profile in patients with diabetes mellitus type 2.
Study design:
Cross-over open-label intervention study.
Study population:
Patients with diabetes mellitus type 2, age 30-75y, body mass index 25-40 kg/m2.
Intervention:
Isoenergetic breakfast replacement by a low-GI liquid meal.
Main study parameters/endpoints:
24-hour glucose profile, body weight, HbA1c, insulin sensitivity, lipid profile.
Doel van het onderzoek
N/A
Onderzoeksopzet
Every 6 weeks: Fasting glucose, insulin, HbA1c and lipid concentrations, oxidative stress, body weight, continuous glucose monitoring;
Every 12 weeks: Postprandial glucose and insulin concentrations and oral glucose tolerance test.
Onderzoeksproduct en/of interventie
Isoenergetic replacement of regular whole-food breakfast by Glucerna SR drinkvoeding (Abbott Laboratories B.V., Zwolle, Netherlands) will be compared to regular whole-food breakfast. Both will be given during 12 weeks.
Publiek
P.H.L.T. Bisschop
Amsterdam 1105 AZ
The Netherlands
+31 (0)20 5666071
p.h.bisschop@amc.uva.nl
Wetenschappelijk
P.H.L.T. Bisschop
Amsterdam 1105 AZ
The Netherlands
+31 (0)20 5666071
p.h.bisschop@amc.uva.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. DM2;
2. Age 30-75y;
3. Body mass index 25-40 kg/m2.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Use of any other anti-diabetic drug than metformin;
2. Acute or chronic metabolic disease (other than diabetes) that will impair metabolism or digestion and absorption of food, including gastrointestinal, hepatic or renal disease;
3. Regular breakfast skipping;
4. Inability to give written informed consent.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL2645 |
NTR-old | NTR2773 |
Ander register | METC AMC : 10/095 |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |
Samenvatting resultaten
patients with type 2 diabetes: a randomised clinical trial. </i> British Journal of Nutrition (2014), 112, 504–512